science

CVS to Cover Lilly GLP-1 Medications for Weight Management

CVS will add coverage for two GLP-1 medications produced by Eli Lilly. The decision expands access for millions of Americans seeking treatment for weight management.

May 28, 3:08 PM(46 days ago)·1m read1 source

CVS to Cover Lilly GLP-1 Medications for Weight Management

Audio version

Tap play to generate a narrated version.

Developing·Limited corroboration so far. This page will refresh as more sources emerge.

The medications are the oral tablet Foundayo and the injectable Zepbound.

MarketWatch reported that the coverage change will take effect soon. The move follows earlier decisions by other insurers to add similar products to their formularies.

MarketWatch stated that millions of additional Americans may now qualify for coverage. Patients will still need a prescription and meet plan-specific clinical criteria. No timeline was provided for when the new coverage will appear in member portals or pharmacy systems.

healthcare insurance biotech

Transparency

How sources framed this

Single source — no framing comparison available.

CorroborationModerate · 1 source

Story details

Live-Action Moana Opens to $95 Million, Tops Domestic Box Office

Disney's live-action remake earned $43 million in the United States and Canada and $52 million internationally over its first three days. The $250 million film finished first at the domestic box office despite falling short of studio estimates.